119 related articles for article (PubMed ID: 8528996)
1. Ginkgolide BN 52021 protects against hemorrhagic shock-induced renal injury in rats.
Kirejczyk JK; Chyczewski L; Debek W
Rocz Akad Med Bialymst; 1995; 40(1):65-76. PubMed ID: 8528996
[TBL] [Abstract][Full Text] [Related]
2. Oxygen-derived free radicals in kidney in experimental hemorrhagic shock treated by PAF-receptor antagonist BN 52021.
Kirejczyk JK; Debek W; Dziecioł J; Chyczewski L; Makarewicz M; Nikliński J
Rocz Akad Med Bialymst; 1995; 40(1):77-87. PubMed ID: 8528997
[TBL] [Abstract][Full Text] [Related]
3. Luminol-chemiluminescence in free peritoneal cells in hemorrhagic shock in rats treated with PAF-receptor-antagonist BN 52021.
Debek W; Gruca P; Chyczewski L; Gruca A
Rocz Akad Med Bialymst; 1995; 40(1):129-37. PubMed ID: 8528982
[TBL] [Abstract][Full Text] [Related]
4. Protection of platelet-activating factor-induced acute renal failure by BN 52021.
Pirotzky E; Colliez P; Guilmard C; Schaeverbeke J; Mencia-Huerta JM; Braquet P
Br J Exp Pathol; 1988 Apr; 69(2):291-9. PubMed ID: 3377967
[TBL] [Abstract][Full Text] [Related]
5. Role of platelet-activating factor in hepatocellular Ca2+ alterations during hemorrhagic shock.
Silomon M; Pizanis A; Larsen R; Rose S
J Surg Res; 1997 Oct; 72(2):101-6. PubMed ID: 9356229
[TBL] [Abstract][Full Text] [Related]
6. Platelet-activating factor antagonists treatment protects against postischemic acute renal failure in rats.
López-Farré A; Bernabeu F; Gómez-Garre D; Ramon y Cajal S; Braquet P; López-Novoa JM
J Pharmacol Exp Ther; 1990 Apr; 253(1):328-33. PubMed ID: 2329516
[TBL] [Abstract][Full Text] [Related]
7. Effect of a platelet-activating factor (PAF) receptor antagonist on hyperacute xenograft rejection; evaluation in a pig kidney-human blood xenoperfusion model.
Cruzado JM; Torras J; Riera M; Lloberas N; Herrero I; Condom E; Martorell J; Alsina J; Grinyó JM
Clin Exp Immunol; 1998 Jul; 113(1):136-44. PubMed ID: 9697996
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor antagonists as therapeutic strategy in sepsis.
Dhainaut JF; Mira JP; Brunet F
Prog Clin Biol Res; 1994; 388():277-93. PubMed ID: 7831364
[No Abstract] [Full Text] [Related]
9. Preparation of 7-substituted ginkgolide derivatives: potent platelet activating factor (PAF) receptor antagonists.
Vogensen SB; Strømgaard K; Shindou H; Jaracz S; Suehiro M; Ishii S; Shimizu T; Nakanishi K
J Med Chem; 2003 Feb; 46(4):601-8. PubMed ID: 12570381
[TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor receptor-antagonist (BN 52021) stabilizes the oxidative-antioxidative balance and attenuates the morphological changes in the gastrointestinal tract in experimental hemorrhagic shock.
Debek W; Chyczewski L; Makarewicz M
Exp Toxicol Pathol; 1998 Mar; 50(1):19-25. PubMed ID: 9570497
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of hippocampal LTP by ginkgolide B is mediated by its blocking action on PAF rather than glycine receptors.
Kondratskaya EL; Pankratov YV; Lalo UV; Chatterjee SS; Krishtal OA
Neurochem Int; 2004 Feb; 44(3):171-7. PubMed ID: 14568560
[TBL] [Abstract][Full Text] [Related]
12. Role of platelet activating factor in endotoxemic acute renal failure in the male rat.
Tolins JP; Vercellotti GM; Wilkowske M; Ha B; Jacob HS; Raij L
J Lab Clin Med; 1989 Mar; 113(3):316-24. PubMed ID: 2538527
[TBL] [Abstract][Full Text] [Related]
13. Inhibition by BN 52021 (ginkgolide B) of the binding of [3H]-platelet-activating factor to human neutrophil granulocytes.
Földes-Filep E; Braquet P; Filep J
Biochem Biophys Res Commun; 1987 Nov; 148(3):1412-7. PubMed ID: 2825685
[TBL] [Abstract][Full Text] [Related]
14. Role of platelet-activating factor in long-term potentiation of the rat medial vestibular nuclei.
Grassi S; Francescangeli E; Goracci G; Pettorossi VE
J Neurophysiol; 1998 Jun; 79(6):3266-71. PubMed ID: 9636125
[TBL] [Abstract][Full Text] [Related]
15. BN 52021, PAF-receptor antagonist, improves diminished antioxidant defense system of lungs in experimentally induced haemorrhagic shock.
Makarewicz-Płońska M; Witek A; Farbiszewski R
Pol J Pharmacol; 1998; 50(3):265-9. PubMed ID: 9861635
[TBL] [Abstract][Full Text] [Related]
16. Effects of platelet-activating factor on electrophysiology of isolated retinas and their inhibition by BN 52021, a specific PAF-acether receptor antagonist.
Doly M; Bonhomme B; Braquet P; Chabrier PE; Meyniel G
Immunopharmacology; 1987 Jun; 13(3):189-94. PubMed ID: 3038784
[TBL] [Abstract][Full Text] [Related]
17. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
Baroggi N; Etienne A; Braquet P
Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
[TBL] [Abstract][Full Text] [Related]
18. Effects of antioxidants and PAF receptor antagonist in intestinal shock in the rat.
Haglind E; Xia G; Rylander R
Circ Shock; 1994 Feb; 42(2):83-91. PubMed ID: 8013065
[TBL] [Abstract][Full Text] [Related]
19. Ginkgolide derivatives for photolabeling studies: preparation and pharmacological evaluation.
Strømgaard K; Saito DR; Shindou H; Ishii S; Shimizu T; Nakanishi K
J Med Chem; 2002 Aug; 45(18):4038-46. PubMed ID: 12190325
[TBL] [Abstract][Full Text] [Related]
20. Endothelium-dependent vasodilation in the isolated rabbit kidney following in vivo and in vitro ischaemia and reperfusion: effects of antagonizing platelet activating factor (PAF).
Uluoglu C; Timlioglu O
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):324-30. PubMed ID: 10543435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]